# FDA Inspection 1302210 - SPFM, LLC - February 06, 2026

Source: https://www.keypedia.com/records/fda_inspections/spfm-llc/81d794ea-2b3d-4619-90e6-838488b180e9
Source feed: FDA_Inspections

> FDA Inspection 1302210 for SPFM, LLC on February 06, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302210
- Company Name: SPFM, LLC
- Inspection Date: 2026-02-06
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 912600 - 2015-02-04](https://www.keypedia.com/records/fda_inspections/spfm-llc/5209e2d3-08ad-4b54-8515-8a154255b1eb)
- [FDA Inspection 732289 - 2011-06-21](https://www.keypedia.com/records/fda_inspections/spfm-llc/17b18d71-17ad-42ad-9959-8249166a3929)
- [FDA Inspection 732289 - 2011-06-21](https://www.keypedia.com/records/fda_inspections/spfm-llc/32e30a76-9219-43d9-bb68-0bfd35219c54)
- [FDA Inspection 732289 - 2011-06-21](https://www.keypedia.com/records/fda_inspections/spfm-llc/d16a5ead-564b-4aa1-adad-29929f1518c9)

Company: https://www.keypedia.com/companies/spfm-llc/6da18fe4-fb3f-480b-a68d-d6523529e717

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9